FDA Approves Decnupaz for Rare Blood Cancer
The FDA just approved a new treatment for adults with blastic plasmacytoid dendritic cell neoplasm, an extremely rare and aggressive blood cancer. This marks new hope for patients facing a disease with very few treatment options.